David Chong
Psychiatry · Gilbert, AZNPI 1467897330
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 233 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $810 and has fallen 61.7% since, to $310 in 2025. Among psychiatry clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 233 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$903
- Lundbeck LLC$594
- Otsuka America Pharmaceutical, Inc.$427
- Takeda Pharmaceuticals U.S.A., Inc.$407
- Axsome Therapeutics, Inc.$236
- Vanda Pharmaceuticals Inc.$191
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,91097%
- Education$1073%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 69 | $903 |
| Lundbeck LLC | 35 | $594 |
| Otsuka America Pharmaceutical, Inc. | 22 | $427 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $407 |
| Axsome Therapeutics, Inc. | 11 | $236 |
| Vanda Pharmaceuticals Inc. | 9 | $191 |
| Alfasigma USA, Inc. | 9 | $174 |
| Idorsia Pharmaceuticals US Inc | 9 | $158 |
| Alkermes, Inc. | 8 | $149 |
| Bausch Health US, LLC | 7 | $145 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $144 |
| Almatica Pharma LLC | 6 | $126 |
| Corium, LLC | 2 | $112 |
| Sunovion Pharmaceuticals Inc. | 4 | $67 |
| Shire North American Group Inc | 3 | $54 |
| Johnson & Johnson | 2 | $44 |
| Harmony Biosciences LLC | 1 | $20 |
| Tris Pharma Inc | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $16 |
How this compares
$4,017 in reported general payments places this provider in the 90th percentile of 573 psychiatry providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vilazodone Hcl | 11 | $645 |
| Bupropion XlBupropion Hcl | 21 | $442 |
| Duloxetine Hcl | 17 | $252 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 17 | $181 |
| Lorazepam | 21 | $161 |
| Alprazolam | 15 | $112 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Gilbert
- Richard BurtonGilbert$14K
- Aaron DahlGilbert$12K
- Justin McKinleyGilbert$6K
- Jason CaplanPhoenix$999K
- Thomas GazdaPhoenix$714K
- Monica BenavidezPhoenix$435K
- Bahar GolestanMesa$234K
- Eric ReimanPhoenix$157K
- Christopher LinskeyPage$100K
- Henry SchulteScottsdale$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.